International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease

P. Martinez-Martin, C. Rodriguez-Blazquez, K. Abe, K. B. Bhattacharyya, B. R. Bloem, F. J. Carod-Artal, R. Prakash, R. A.J. Esselink, C. Falup-Pecurariu, M. Gallardo, P. Mir, Y. Naidu, A. Nicoletti, K. Sethi, Y. Tsuboi, J. J. Van Hilten, M. Visser, M. Zappia, K. R. Chaudhuri

Research output: Contribution to journalArticle

158 Scopus citations

Abstract

BACKGROUND: Nonmotor symptoms (NMS) have a great impact on patients with Parkinson disease (PD). The Non-Motor Symptoms Scale (NMSS) is an instrument specifically designed for the comprehensive assessment of NMS in patients with PD. NMSS psychometric properties have been tested in this study. METHODS: Data were collected in 12 centers across 10 countries in America, Asia, and Europe. In addition to the NMSS, the following measures were applied: Scales for Outcomes in Parkinson's Disease (SCOPA)-Motor, SCOPA-Psychiatric Complications (SCOPA-PC), SCOPA-Cognition, Hoehn and Yahr Staging (HY), Clinical Impression of Severity Index for Parkinson's Disease (CISI-PD), SCOPA-Autonomic, Parkinson's Disease Sleep Scale (PDSS), Parkinson's Disease Questionnaire-39 items (PDQ-39), and EuroQol-5 dimensions (EQ-5D). NMSS acceptability, reliability, validity, and precision were analyzed. RESULTS: Four hundred eleven patients with PD, 61.3% men, were recruited. The mean age was 64.5 ± 9.9 years, and mean disease duration was 8.1 ± 5.7 years. The NMSS score was 57.1 ± 44.0 points. The scale was free of floor or ceiling effects. For domains, the Cronbach α coefficient ranged from 0.44 to 0.85. The intraclass correlation coefficient (0.90 for the total score, 0.67-0.91 for domains) and Lin concordance coefficient (0.88) suggested satisfactory reproducibility. The NMSS total score correlated significantly with SCOPA-Autonomic, PDQ-39, and EQ-5D (rS = 0.57-0.70). Association was close between NMSS domains and the corresponding SCOPA-Autonomic domains (rS = 0.51-0.65) and also with scales measuring related constructs (PDSS, SCOPA-PC) (all p < 0.0001). The NMSS total score was higher for women (p < 0.02) and for increasing disease duration, HY, and CISI-PD severity level (p < 0.001). The SEM was 13.91 for total score and 1.71 to 4.73 for domains. CONCLUSION: The Non-Motor Symptoms Scale is an acceptable, reproducible, valid, and precise assessment instrument for nonmotor symptoms in Parkinson disease.

Original languageEnglish (US)
Pages (from-to)1584-1591
Number of pages8
JournalNeurology
Volume73
Issue number19
DOIs
StatePublished - Nov 2009

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease'. Together they form a unique fingerprint.

  • Cite this

    Martinez-Martin, P., Rodriguez-Blazquez, C., Abe, K., Bhattacharyya, K. B., Bloem, B. R., Carod-Artal, F. J., Prakash, R., Esselink, R. A. J., Falup-Pecurariu, C., Gallardo, M., Mir, P., Naidu, Y., Nicoletti, A., Sethi, K., Tsuboi, Y., Van Hilten, J. J., Visser, M., Zappia, M., & Chaudhuri, K. R. (2009). International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease. Neurology, 73(19), 1584-1591. https://doi.org/10.1212/WNL.0b013e3181c0d416